Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Jul 8:15:1651566.
doi: 10.3389/fonc.2025.1651566. eCollection 2025.

Editorial: Molecular markers for pancreatic cancers: new technologies and applications in the clinical practice

Terence Moyana  1 , Valeria Merz  2
Affiliations
Editorial

Editorial: Molecular markers for pancreatic cancers: new technologies and applications in the clinical practice

Terence Moyana et al. Front Oncol. .
No abstract available

Keywords: circulating biomarkers; exosomes; major vault protein; molecular markers; pancreatic ductal adenocarcinoma; transcriptomic tools.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Comment on

  • Editorial on the Research Topic Molecular markers for pancreatic cancers: new technologies and applications in the clinical practice

References

    1. Ren B, Liu X, Suriawinata AA. Pancreatic ductal adenocarcinoma and its precursor lesions: histopathology, cytopathology, and molecular pathology. Am J pathology. (2019) 189(1):9–21. doi: 10.1016/j.ajpath.2018.10.004, PMID: - DOI - PubMed
    1. Chiaravalli M, Reni M, O'Reilly EM. Pancreatic ductal adenocarcinoma: State-of-the-art 2017 and new therapeutic strategies. Cancer Treat Rev. (2017) 60:32–43. doi: 10.1016/j.ctrv.2017.08.007, PMID: - DOI - PubMed
    1. Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin. (2024) 74(3):229–63. doi: 10.3322/caac.21834, PMID: - DOI - PubMed
    1. Ilic I, Ilic M. International patterns in incidence and mortality trends of pancreatic cancer in the last three decades: A joinpoint regression analysis. World J gastroenterology. (2022) 28(32):4698. doi: 10.3748/wjg.v28.i32.4698, PMID: - DOI - PMC - PubMed
    1. Khalaf N, El-Serag HB, Abrams HR, Thrift AP. Burden of pancreatic cancer: from epidemiology to practice. Clin Gastroenterol Hepatology. (2021) 19(5):876–84. doi: 10.1016/j.cgh.2020.02.054, PMID: - DOI - PMC - PubMed

Publication types

LinkOut - more resources